1. Home
  2. CRGX vs MPB Comparison

CRGX vs MPB Comparison

Compare CRGX & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • MPB
  • Stock Information
  • Founded
  • CRGX 2021
  • MPB 1868
  • Country
  • CRGX United States
  • MPB United States
  • Employees
  • CRGX N/A
  • MPB N/A
  • Industry
  • CRGX
  • MPB Major Banks
  • Sector
  • CRGX
  • MPB Finance
  • Exchange
  • CRGX Nasdaq
  • MPB Nasdaq
  • Market Cap
  • CRGX 628.6M
  • MPB 525.0M
  • IPO Year
  • CRGX 2023
  • MPB N/A
  • Fundamental
  • Price
  • CRGX $3.74
  • MPB $29.57
  • Analyst Decision
  • CRGX Hold
  • MPB Buy
  • Analyst Count
  • CRGX 7
  • MPB 2
  • Target Price
  • CRGX $4.67
  • MPB $36.00
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • MPB 71.0K
  • Earning Date
  • CRGX 03-20-2025
  • MPB 01-22-2025
  • Dividend Yield
  • CRGX N/A
  • MPB 2.74%
  • EPS Growth
  • CRGX N/A
  • MPB 14.41
  • EPS
  • CRGX N/A
  • MPB 2.91
  • Revenue
  • CRGX N/A
  • MPB $173,416,000.00
  • Revenue This Year
  • CRGX N/A
  • MPB N/A
  • Revenue Next Year
  • CRGX N/A
  • MPB $19.26
  • P/E Ratio
  • CRGX N/A
  • MPB $10.05
  • Revenue Growth
  • CRGX N/A
  • MPB 4.93
  • 52 Week Low
  • CRGX $3.00
  • MPB $19.20
  • 52 Week High
  • CRGX $33.92
  • MPB $33.87
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • MPB 50.09
  • Support Level
  • CRGX $3.00
  • MPB $28.44
  • Resistance Level
  • CRGX $3.88
  • MPB $31.36
  • Average True Range (ATR)
  • CRGX 0.92
  • MPB 0.74
  • MACD
  • CRGX -1.00
  • MPB 0.07
  • Stochastic Oscillator
  • CRGX 5.99
  • MPB 42.47

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.

Share on Social Networks: